AWARD OUTCOME
What happened
University Hospital Southampton NHS Foundation Trust published a Provider Selection Regime call-off award for a fully managed insourced dermatology service, including minor operations and weekend teams targeting elective backlogs. The published contract record names 18 WEEK SUPPORT LIMITED as supplier and records a signed contract value of £2,168,400.
Published outcomeOne active award and active contract record are linked to 18 WEEK SUPPORT LIMITED for lot 1. The contract record explicitly gives a signature date of 20 October 2026.
Market significanceThis is a new NHS dermatology capacity requirement delivered through a framework call-off without further competition, focused on backlog activity at University Hospital Southampton sites.
AWARDED SUPPLIERS AND LOTS
1 supplier record analysed
18 WEEK SUPPORT LIMITED
98% confidenceAward 099047-2026-WPL06817-1 · Lots 1 · £2,168,400 is recorded for the linked contract; the notice describes this as total estimated lifetime value including the optional extension. GBP · Verified supplier; linked award and contract active
View supporting evidence
Supplier verification matched Companies House number 11880370 to 18 WEEK SUPPORT LIMITED. The award names the supplier and the linked contract records £2,168,400.
LIFECYCLE
Award or contract stage
Published notice status
98% confidenceAward and contract notice published; process status complete
View supporting evidence
Process display status is 'awarded', source status is 'complete', and release tags are award and contract.
Award record
98% confidenceActive
View supporting evidence
Award 099047-2026-WPL06817-1 has status 'active'.
Contract record
98% confidenceActive and explicitly recorded as signed
View supporting evidence
Contract 099047-2026-WPL06817-1 has status 'active' and dateSigned of 2026-10-20.
Lot record
99% confidenceCancelled
View supporting evidence
Lot 1 is marked 'cancelled' despite the linked award and contract records being active.
VALUES
Published values explained
Published contract value
98% confidence£2,168,400
View supporting evidence
The linked contract record states GBP 2,168,400.
Value interpretation
96% confidenceEstimated lifetime value including the optional 12-month extension
View supporting evidence
Lot description states that total estimated lifetime value including the optional extension is £2,168,400.
TIMELINE
Procurement timeline
Contract commencement recorded in notice narrative
94% confidence16 April 2026
View supporting evidence
Lot description states that the contract commences on 16/04/2026.
Initial period expiry recorded in notice narrative
94% confidence15 April 2027
View supporting evidence
Lot description states that the initial period expires on 15/04/2027.
Contract signature date
98% confidence20 October 2026
View supporting evidence
Linked contract dateSigned is 2026-10-20.
Notice publication date
98% confidence20 October 2026
View supporting evidence
Process published_at is 2026-10-20T14:17:45+01:00.
Latest stated extension limit
93% confidence15 May 2028
View supporting evidence
Lot description states that the optional extension will not extend beyond 15/05/2028.
SCOPE
What was awarded
Service
98% confidenceFully managed insourced clinical dermatology service, including minor operations
View supporting evidence
Tender and lot descriptions.
Clinical activity
97% confidenceDedicated weekend clinical teams targeting elective dermatology backlogs
View supporting evidence
Lot description.
Supplier responsibilities
98% confidenceOrganisation, management and delivery of services, including provision, supervision and management of supplier personnel
View supporting evidence
Tender description.
Delivery area
96% confidenceUniversity Hospital Southampton Trust sites; UKJ32 delivery region
View supporting evidence
Tender description and delivery-address item.
Classification
99% confidenceCPV 85121282 — Dermatology services
View supporting evidence
Primary tender classification.
Requirement type
94% confidenceNew service requirement
View supporting evidence
Lot description states: 'This is a new service requirement.'
PROCEDURE
Procedure and competition
Route to market
98% confidenceFramework call-off without further competition
View supporting evidence
Lot description confirms an award based on a framework agreement without further competition.
Procedure
98% confidenceLimited procedure / award procedure without prior publication of a call for competition
View supporting evidence
Process procurement method and procurement method details.
Regulatory regime
98% confidenceHealth Care Services (Provider Selection Regime) Regulations 2023
View supporting evidence
Tender rationale and review details.
Evaluation information
85% confidenceFramework criteria described as cost: 100
View supporting evidence
Lot award criteria lists 'Criteria as described in the framework agreement', type cost, description 100.
Competition information
99% confidenceNot supplied in the published notice
View supporting evidence
No bid, participant or competition-count data is provided.
CONTRACT TERMS
Published contract terms
Initial term
94% confidence16 April 2026 to 15 April 2027, as stated in the notice narrative
View supporting evidence
Lot description.
Extension
94% confidenceOne optional extension stated as 12 months
View supporting evidence
Lot description.
Maximum stated end point
93% confidenceExtension will not extend beyond 15 May 2028
View supporting evidence
Lot description.
Standstill and challenge
96% confidenceNo statutory standstill period or PSR representation process stated; formal challenge route stated as the High Court under Civil Procedure Rules
View supporting evidence
Tender review details.
COMMERCIAL VIEW
Commercial observations
Capacity focus
97% confidenceThe requirement is directed at elective dermatology backlog activity, with weekend delivery and minor operations included.
View supporting evidence
Lot description.
Commercial structure
94% confidenceThe published £2,168,400 is a lifetime estimate that includes the optional extension, rather than a separately published initial-term and extension pricing breakdown.
View supporting evidence
Lot description and linked contract value.
Route implication
97% confidenceThe award was made through an existing framework without further competition; the notice does not publish competing suppliers or bid comparisons.
View supporting evidence
Lot description and absence of competition data.
DATA QUALITY
Gaps and source limitations
Conflicting lifecycle fields
99% confidenceThe linked award and contract are active, while the sole linked lot is marked cancelled. The analysis does not resolve this contradiction or treat the lot status as evidence that the active contract is cancelled.
View supporting evidence
Award and contract statuses are active; lot 1 status is cancelled.
Date sequencing
98% confidenceThe notice narrative records commencement on 16 April 2026, whereas the contract signature and publication dates are both 20 October 2026. The source does not explain the sequence.
View supporting evidence
Lot narrative, contract dateSigned, and process published_at.
Term inconsistency
96% confidenceA 12-month extension after the stated 15 April 2027 initial expiry would not directly align with the separately stated latest end date of 15 May 2028. The notice does not explain the difference.
View supporting evidence
Lot description.
Supplier identity quality
99% confidenceSupplier identity is verified against Companies House number 11880370; no supplier-name mismatch was flagged.
View supporting evidence
Supplier verification record.
Unpublished information
99% confidenceInformation not supplied in the published notice includes bid count, participant names, scoring detail, pricing breakdown, lot-specific value, and explanation of the lifecycle contradictions.
View supporting evidence
No such fields are supplied in the source data.
SOURCE DATA LIMITATIONS
Information not supplied in the published notice
- The sole linked lot is marked cancelled while the award and contract records are active; the source provides no explanation.
- The recorded commencement date predates the recorded contract signature and notice publication dates; the source provides no explanation.
- The stated optional 12-month extension and latest possible end date do not fully align from the stated initial expiry date.
- Information not supplied in the published notice includes competition counts, bid prices, award scoring detail, separate initial and extension values, and lot-specific value allocation.
MARKET THEMES
Relevant award themes
University Hospital Southamptondermatology insourcing18 WEEK SUPPORT LIMITEDNHS dermatology servicesWPL06817Provider Selection Regimeframework call-off
COMMON QUESTIONS
About this award
Who was named as supplier for the dermatology insourcing award?
18 WEEK SUPPORT LIMITED, verified against Companies House number 11880370.
What value was published?
The linked contract records £2,168,400. The notice describes this as the estimated lifetime value including the optional extension.
Was this competed through a new tender?
The notice states it was a framework call-off made without further competition under the Provider Selection Regime.
Is the contract active?
The award and contract records are active and the contract has an explicit signature date. However, the linked lot is marked cancelled, creating an unresolved source-data contradiction.
ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.